What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2024-04-23 compared with 2023-10-24 · 63 added, 15 removed, 33 unchanged (70% of the section changed)

Other Information

During the three months ended September 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:

During the three months ended March 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:

Action Date Trading Arrangement Total Shares to be Purchased or Sold Duration/Expiration Date

Rule 10b5-1* Non-Rule 10b5-1**

Ewald , General Counsel and Corporate Secretary

Adopt Post-market close on

July 26, 2023 [1]

Medpace Investors, LLC [1] Adopt February 16, 2024 [2]

X Up to 50,000 shares to be sold

The earlier of until cancelled or 180 days from the placement of the limit order

Brady , Chief Financial Officer and Treasurer

Adopt July 31, 2023 [2]

Good until cancelled

Medpace Investors, LLC [1] Adopt February 20, 2024 [3]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt February 22, 2024 [4]

X Up to 100,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt February 23, 2024 [5]

X Up to 156,928 shares to be sold

Good until cancelled

Keating , Director

Adopt February 26, 2024 [6]

X Up to 1,972 shares to be sold

The earlier of until cancelled or 180 days from the placement of the limit order

Medpace Investors, LLC [3] Terminate [4] September 21, 2023 X Up to 500,000 shares to be sold

September 14, 2024

Medpace Investors, LLC [1] Adopt February 27, 2024 [7]

X Up to 100,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt February 29, 2024 [8]

X Up to 100,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt March 4, 2024 [9]

X Up to 100,000 shares to be sold

Good until cancelled

Geiger , President

Adopt March 4, 2024 [10]

X Up to 22,321 shares to be sold

March 4, 2024

Medpace Investors, LLC [1] Adopt March 6, 2024 [11]

X Up to 100,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt March 7, 2024 [12]

X Up to 100,000 shares to be sold

Good until cancelled

Burwig , Executive Vice President, Operations

Adopt March 15, 2024 [13]

X Up to 7,783 shares to be sold

March 15, 2024

* Intended to satisfy the affirmative defense of Rule 10b5-1(c).

** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).

[1] Post-market close on July 26, 2023, Mr.

Ewald placed a limit order to sell up to 21,850 shares issued to him pursuant to his contemporaneous exercise of stock options.

[2] On July 31, 2023, Mr.

Brady placed a limit order to sell up to 7,000 shares issued to him pursuant to his contemporaneous exercise of stock options.

[1] August J.

1 unchanged sentence

Troendle may be deemed to indirectly beneficially own the securities of the Company held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

[4] Trading arrangement was originally adopted on May 1, 2023 .

[2] On February 16, 2024 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[3] On February 20, 2024 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[4] On February 22, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired through open market purchases.

[5] On February 23, 2024 , MPI placed a limit order to sell up to 156,928 shares that were previously acquired through open market purchases.

[6] On February 26, 2024 , Ms.

Keating placed multiple limit orders at multiple different prices to sell up to 1,972 shares issued to her pursuant to her contemporaneous exercise of stock options.

On March 14, 2024, Ms.

Keating cancelled her last sell order and executed a sell to cover trade.

[7] On February 27, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.

[8] On February 29, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.

[9] On March 4, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.

[10] On March 4, 2024 , Mr.

Geiger placed a limit order to sell up to 22,321 shares issued to him pursuant to his contemporaneous exercise of stock options.

[11] On March 6, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.

[12] On March 7, 2024 , MPI placed a limit order to sell up to 100,000 shares that were previously acquired from the Company as part of a transaction with a private equity firm.

[13] On March 15, 2024 , Ms.

Burwig placed a limit order to sell up to 7,783 shares that were acquired upon the vesting of restricted shares.

The exhibits in the accompanying Exhibit Index preceding the signature page are filed or furnished as a part of this report and are incorporated herein by reference.

3 unchanged sentences

Exhibit Filing

#10.1 Form of Medpace Holdings, Inc.

2016 Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement

#10.2 Form of Medpace Holdings, Inc.

2016 Incentive Award Plan Restricted Stock Unit Award Grant Notice

10.3 Amendment No.

6 dated March 2 8 , 202 4 to Loan Documents

8-K 001-37856 10.1 3/29/2024

31.1 Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer

11 unchanged sentences

** Furnished herewith.

# Indicates management contract or compensatory plan.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

2 unchanged sentences

(Principal Financial Officer)

October 24, 2023

April 23, 2024

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information